BioSpace News Archive

Business

Perrigo Company plc Reports Second Quarter 2018 Financial Results

Realized second quarter 2018 GAAP (“reported”) net sales of $1.2 billion, reported net income of $36 million compared to a net loss of $70 million last year and reported diluted earnings per share (“EPS”) of $0.26 compared to losses per share of $0.49 last year

August 9, 2018
·
70 min read
Deals

Ligand Makes Offer to Acquire Vernalis, a Leader in Structure-Based Drug Discovery, For Approximately $43 Million in Cash

Ligand to gain broad portfolio of partnered and unpartnered programs, a self-funding R&D group and approximately $32 million of net cash

August 9, 2018
·
8 min read
Business

Cura Goes International with Cronos Group Inc.

Cura is on a mission to be the leading provider of premium cannabis oil and hemp oil to the legal U.S. and international markets, and will enter the Canadian market to supply domestic and international channels through this agreement.

August 9, 2018
·
6 min read
Business

Evolva on Track to Deliver on Set Targets

Evolva (SIX:EVE) posted its financial results today and provided business highlights for the period from 1 January to 30 June 2018.

August 9, 2018
·
3 min read
Drug Development

NSW Health Funds Indee Labs’ First Preclinical Study Into Gene-Modified Cell Therapy Manufacturing for Blood Cancer

This preclinical study will pave the way for biopharmaceutical companies to transition away from using viruses.

August 9, 2018
·
4 min read
Job Trends

Newly Published Independent Study on a Prospective Cohort Highlights DecisionDx-Melanoma Prognostic Test’s Ability to Accurately Identify High-Risk Melanoma Patients

Results from this second prospective study are consistent with prior four clinical validation studies

August 9, 2018
·
4 min read